Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berobenatide (PF-08653944) in Chinese Adults with Overweight or Obesity
NCT07874633Phase 3Not yet recruiting
- Sponsor
- Pfizer
- Start
- Oct 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 3 trial of berobenatide in obesity, sponsored by Pfizer. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
berobenatide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07874633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07874633.